Viewing Study NCT00022256


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2025-12-30 @ 8:41 PM
Study NCT ID: NCT00022256
Status: COMPLETED
Last Update Posted: 2013-06-18
First Post: 2001-08-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: MSKCC-01051
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View